中文

Caen Neuroscience PhD: Intestinal MAdCAM-1 and Recovery after Stroke

Project 2118 · Université de Caen Normandie - INSERM · Blood, Brain and Memory @ Caen Normandie institute (BBM@C)

Application workspace

Save this opportunity and prepare around its actual requirements. Confirm deadlines and eligibility at the original source.

Country or region
France
Application deadline
2026-11-16 (confirm the exact time with the source)
Funding
The reopened notice states public funding only. The matching ED497 MAdStroke sheet lists an institutional doctoral contract; personal salary, term, employer and fee/CVEC coverage are unconfirmed.

The research opportunity

Caen Neuroscience PhD: Intestinal MAdCAM-1 and Recovery after Stroke

Research question

The project asks whether intestinal inflammation that predates a stroke is associated with stroke severity and long-term functional recovery, and whether MAdCAM-1 could serve as a prognostic marker. It is a candidate marker, not a validated clinical test; association, prediction and evidence of improved outcomes are distinct questions.

Doctoral work and research setting

The advertised work combines a stroke model with patient-related data. It links MAdCAM-1 imaging with intestinal and central immune analyses, microbiome measures, and neurological and recovery outcomes. Listed methods include molecular/immuno-MRI, flow cytometry, whole-genome sequencing, functional ultrasound and behavioural testing; two research approaches targeting intestinal inflammation are also proposed. The patient-data plan, permissions, division of work and primary endpoints are not specified. The host is PhIND (Inserm UMR-S 1237) at Cyceron in Caen. Lab and platform descriptions are available from BIND Lab and BBM@C; listed facilities do not guarantee access to every platform.

University and training

The degree-awarding institution is Université de Caen Normandie, within doctoral school ED497 NBISE, in molecular and cellular biology. The school normally requires at least 100 training hours, including 50 transversal hours. A non-European master's follows an exceptional admission review; the saved rules cite at least five months of research experience, with individual approval required. See ED497 admission rules and training requirements.

Application and funding

Applicants must hold a master's in neuroscience, neurobiology or biology and the French regulatory animal-research certification or an accepted equivalent, such as FELASA. Proficiency in French or English is required. Relevant imaging, cell-analysis or genomics experience is welcomed.

The saved reopened notice gives a deadline of 16 November 2026, with no time or timezone, and a planned start of 1 February 2027; current application status is unconfirmed. The notice states public funding only. The matching ED497 MAdStroke project sheet lists an institutional doctoral contract and Marina Rubio as thesis director (rubio@cyceron.fr). Continuity for this round, personal salary, appointment length, legal employer and registration-fee/CVEC coverage remain unconfirmed.

Research and application brief

Report generated: . This date does not confirm that recruitment remains open.

Information updated: . Recheck the original notice before applying.

Show report contents

Caen Neuroscience PhD: Intestinal MAdCAM-1 and Recovery after Stroke

Research focus and applicant fit

This translational neuroscience PhD asks whether intestinal inflammation present before stroke is associated with greater severity and poorer long-term recovery. It combines imaging, immune and microbiome evidence with functional outcomes, using preclinical and patient-related observations in Caen's neurovascular research environment. MAdCAM-1 is a candidate prognostic marker, not an already validated clinical test: association, predictive value and evidence of improved recovery require different support.

The clearest applicant match is a research-trained biology, neurobiology or neuroscience Master's graduate who meets the mandatory animal-research certification requirement. Proficiency in French or English is required; prior experience with the named imaging and analytical methods is welcomed, without requiring mastery of every platform.

The saved reopened recruitment notice lists 16 November 2026, with no deadline time, and an intended 1 February 2027 start. Public funding is stated, and the matching MAdStroke doctoral-school sheet names Marina Rubio and an institutional doctoral contract. The reopened offer's personal salary, employment duration and fee coverage remain unconfirmed. The useful first step is to ask Rubio whether this contract and supervision arrangement remain current and obtain written recognition of the applicant's existing certification and degree route.

Research Problem and Doctoral Work

Distinguishing baseline inflammation, prognosis and recovery

The central distinction is between intestinal changes caused by stroke and inflammation that was present beforehand. The project asks whether the latter is associated with greater severity and poorer recovery, and whether addressing intestinal inflammation could improve outcomes. The doctoral-school sheet identifies MAdCAM-1 expression as a candidate prognostic marker, rather than an already validated clinical test. Association, prognosis and evidence of benefit must remain separate claims.

Doctoral work and interpretation

The official MAdStroke description combines preclinical and patient evidence. At a non-procedural level, the advertised work links intestinal MAdCAM-1 imaging with intestinal and central immune profiles, whole-genome sequencing for microbiome analysis, and functional ultrasound and behavioural recovery outcomes. Patient-related work connects intestinal marker and microbiome measurements with neurological deficits and recovery. Two candidate approaches directed at intestinal inflammation are envisaged; the documents do not identify them sufficiently to define a doctoral protocol.

This is an integrated experimental/translational position, with substantial quantitative interpretation across biological, imaging and functional outcomes. It is not advertised as purely computational microbiome analysis or purely clinical patient care. The study allocation, clinical partners, availability of patient data and permissions, and primary endpoints are not specified. Possible discussion points include confounding by age or clinical context, longitudinal versus cross-sectional evidence, and whether a marker adds useful prognostic information. These are analytical questions for supervision discussions, not additional promised work packages.

School, Programme and Field Context

Université de Caen Normandie is the named degree-awarding institution; the research host is the joint Caen/Inserm PhIND unit at Cyceron. The government's 2026 unit register confirms both trustees and Denis Vivien as unit director. Neither Inserm affiliation nor imaging-network participation establishes a separate degree. Normandie University's doctoral framework describes regional coordination and co-accreditation with member establishments, rather than two independent doctorates.

The field is molecular/cellular biology with a neuroscience and translational biomedical focus, within ED497 NBISE. QS's institutional profile places Caen in the 1201–1400 overall band for 2027, also the displayed 2026 band. This is a modest broad institutional signal; no reliable neuroscience subject rank was verified. The stronger project-specific evidence is the joint research unit, imaging environment and directly relevant original publications. These support continued consideration rather than exclusion solely on the university's overall ranking; they do not establish the quality of individual doctoral supervision.

NBISE admission rules require research-qualified degree evidence, written agreement from the HDR-qualified director and host unit, and doctoral-school approval. Holders of a non-European master's use an exceptional-admission review; the page identifies at least five months of relevant research experience in that assessment. This is a qualification-review route, not a nationality ban or automatic recognition of every overseas degree. An early dossier check matters for the February start.

Doctoral training normally requires at least 100 hours, including 50 transversal hours, and a training agreement before defence; the page states a specific exemption for those whose funding is unrelated to the thesis, particularly clinicians. Do not assume that exemption applies here. The advertised personal contract duration is absent. Generic three-year doctoral-contract norms cannot substitute for confirmation of this reopened appointment.

Supervisor and Lab Assessment

Roles and research environment

The project sheet explicitly identifies Marina Rubio as thesis director and gives rubio@cyceron.fr. This is stronger evidence than inferring a supervisor from the unit director. Inserm's study announcement identifies Rubio as an Inserm researcher and research co-leader. The exact current co-supervision, meeting frequency and available mentoring capacity remain unknown.

The saved host description lists advanced imaging infrastructure at Cyceron: small-animal 7T MRI/PET, MPI, two-photon and photoacoustic imaging; team microscopy including confocal/STED, calcium and spinning-disc imaging; Doppler/speckle and fast-ultrasound resources. BBM@C adds sequencing through InnovaSeq, human-sample support through InnovaBIO and advanced microscopy links. These are listed resources, not evidence that a student will independently use every platform or receive unrestricted instrument time. Cyceron's own PhIND page supports the broader integration of neurovascular mechanisms, imaging and clinical translation.

Three original studies: contribution and limits

1. Age changes the interpretation of neuroinflammation. Levard and colleagues, 2024 examine CNS-associated macrophages in stroke with preclinical and human-tissue evidence. Their findings show context-dependent immune coordination during ageing. This makes age and baseline condition important interpretive questions for MAdStroke. It does not validate intestinal MAdCAM-1 as a patient recovery predictor. Rubio is the final and a corresponding author; Vivien is also corresponding. Read: complete abstract, ordered authors, affiliations and citation metadata; the Nature full page was inaccessible. No full-paper or supplement reading is claimed.

2. Imaging can connect vascular inflammation with disease evolution. Glavan and colleagues, 2024 report an original aneurysm study linking inflammatory imaging and neurovascular pathology. It supports relevant lab expertise, while aneurysm evidence and limited human correspondence cannot establish performance in ischemic stroke or intestinal disease. Rubio is final/corresponding, with explicit conceptualisation, funding, supervision and investigation contributions; Vivien's listed roles include funding and supervision. Read: publisher abstract, selected introduction/results overview, author/contribution and citation sections; not the entire article or supplements.

3. Translation needs independent comparative evidence. Correa-Paz and colleagues, 2024 compare acute-stroke therapies in original preclinical research evaluated at two centres. This demonstrates comparative and cross-centre work relevant to research rigour, rather than evidence that gut-directed treatment improves long-term recovery. The two centres count as one paper. Rubio is penultimate, not sole study leader; a publisher-indexed first-page excerpt lists her among corresponding authors. Read: complete PubMed abstract/authors/metadata and the indexed first-page contact excerpt; no full-text/PDF reading claim. The bibliography retains the complete PubMed author order. An earlier publisher-indexed first-page excerpt differs in three names (Pérez-Gayo versus Pérez-Gayol, del Pozo-Filú versus Del Pozo-Filíu, Rodríguez-Yáñez versus Rodríguez-Yañez); the same DOI identifies one study, but the spelling discrepancy remains unresolved because the saved publisher/PDF attempts did not resolve it.

These are three original 2024 articles, not a review plus duplicate manifestations. Only the second was examined beyond abstract/metadata level. They demonstrate a credible neurovascular research direction, while the new intestinal prognostic hypothesis still requires investigation.

Funding, Application and Living Cost

Confirmed category versus actual offer terms

The 2026 school directory and matching project sheet identify an institutional doctoral contract; the reopened notice states public funding without further financial details. No verified personal salary, employment length, employer contract, teaching duties, fee payment or extension commitment was recovered. Nearby directory entries funded by ERC, CAESAR or other schemes concern different projects and must not be transferred to MAdStroke.

The French ministry's funding page gives a generic public doctoral-contract initial duration of three years and a research-only minimum of EUR 2,300 gross monthly from January 2026. This is contextual evidence, not a quoted MAdStroke salary or confirmed three-year appointment. NBISE's admission page still cites EUR 2,044 tied to 2023 and a separate EUR 1,100 foreign/cotutelle threshold. Neither establishes this job's pay; the latter is not an alternative wage offered to overseas recruits. Obtain the applicable written employment terms. No net-income or savings estimate is justified.

The saved notice's deadline is 16 November 2026, date only; a previously collected discovery record specified 23:59 Europe/Paris, which was not independently confirmed in the employer-posted notice. The intended start is 1 February 2027. An Apply control is visible in the recovered notice, but its destination, required attachments and complete submission instructions were not captured in the saved body. Rubio’s contact is supplied by the matching ED497 project sheet, with continuity for this reopened round still to be confirmed. Caen's general doctoral registration guidance suggests a motivation letter, CV and research outline of at most two pages for initial supervisor contact. That is general contact guidance, not a verified complete attachment list for this vacancy.

Budget evidence and limitations

Caen's budget page, updated March 2026, gives indicative rent from EUR 275 for a Crous room to EUR 600 for a private residence, a one-month deposit, insurance around EUR 50/year and university meals at EUR 3.30. It explicitly labels the EUR 397 doctorate registration fee and EUR 105 CVEC as 2025–26 figures. They are not confirmed 2026–27 or February 2027 charges; transport examples also have age conditions. These components are useful for an initial checklist, not a comprehensive budget.

The student-housing page gives a different EUR 254 room example with indicative EUR 85 CAF assistance, reflecting a particular situation. Do not subtract CAF automatically or assume that room exists. The university’s researcher-housing guidance describes very limited Lébisey studios, guarantor requirements and temporary accommodation planning. The Crous 2026 tariff directory lists newer tables effective September 2026, but those numeric tables were not successfully read. Ask for an actual quote and eligibility before budgeting an allocation.

Caen’s researcher residence guidance makes a hosting agreement central to the researcher route and describes a student route where that is unavailable. The appropriate route and current formalities require the host's confirmation; neither recruitment eligibility nor language proficiency guarantees a visa.

Applicant Fit, Preparation and Career Implications

Required in the notice: a master's in neuroscience, neurobiology or biology; French regulatory animal-research certification or an accepted equivalent such as FELASA accreditation; French or English proficiency. The certification is mandatory, rather than an optional skill to acquire casually after entry. Its recognised level, equivalence and possession deadline require written checking. No numeric GPA, IELTS threshold or general nationality exclusion was verified.

Preferred: prior small-animal MRI, flow-cytometry or genomic-analysis experience. The notice appreciates these skills; it does not require mastery of all platforms. Strong preclinical/translational interest and willingness to connect gut and CNS evidence matter. Purely software-oriented applicants without the required biology degree/certification would face a substantive eligibility gap.

Suggested preparation: document the research question, personal analytical contribution, reproducibility and limitations of previous work; provide degree/transcript and research-duration evidence for ED review; explain why multimodal observations can disagree without claiming a ready-made causal answer. A short project discussion should separate patient associations, prognostic validation and preclinical evidence. These are preparation suggestions, not additional advertised tests.

Career relevance

The project could build skills useful in neurovascular academic research, imaging analysis and translational R&D, but the saved material contains no programme-specific graduate-placement evidence. SIES's September 2024 note on the 2020 doctorate cohort reports life-sciences insertion of 88.0% among economically active graduates, employment of 83.9% of the whole cohort, and stable employment of 39.7% among those employed, one year later. Denominators differ. This pandemic-era national evidence highlights early-career instability; it is neither a Caen outcome nor a forecast for a 2027 entrant.

Next Actions and Questions to Verify

Before applying

  1. Ask Marina Rubio whether the reopened position retains the MAdStroke institutional contract and her direction; request exact application documents and deadline time.

  2. Send the certification title and issuing institution for written equivalence recognition and clarify when it must be held.

  3. Ask ED497 about non-European master's review, the five-month research-experience evidence and the February registration timetable.

At interview

  1. Establish the preclinical/patient work split, available clinical data and permissions, main recovery outcomes and feasible milestones.

  2. Discuss supervision frequency, co-supervisors, quantitative-analysis support and access to the named platforms.

  3. Ask how age, baseline inflammation and other clinical differences will affect interpretation, without assuming the candidate marker is already validated.

Before accepting

Obtain the employing entity, gross salary, funded months, duties, fees/CVEC treatment, extension policy and hosting-agreement route in writing. Secure current housing quotes and temporary-arrival arrangements. Resolve these material conditions before treating a public-funding category as a complete financial offer.

Evidence and Sources

This assessment uses recruitment, institutional and publication records saved in October 2026. The reopened notice and matching doctoral-school sheet remain separate evidence for the proposed appointment; neither establishes present availability or continuity of its personal contract. The paper-specific abstract, selected-section and indexed-first-page limits above remain in force, including the unresolved name-spelling discrepancies. No new external verification or paper-body reading is claimed.

Project, institution and training

Complete publication bibliography

  1. Damien Levard; Célia Seillier; Mathys Bellemain-Sagnard; Antoine Philippe Fournier; Eloïse Lemarchand; Chantal Dembech; Gaëtan Riou; Karina McDade; Colin Smith; Conor McQuaid; Axel Montagne; Lukas Amann; Marco Prinz; Denis Vivien; Marina Rubio. Central nervous system-associated macrophages modulate the immune response following stroke in aged mice. Nature Neuroscience 27(9), 1721–1733. DOI 10.1038/s41593-024-01695-3. Online 2024-07-03; issue 2024-09. Exact issue day unconfirmed. Primary bibliographic record.

  2. Martina Glavan; Ana Jelic; Damien Levard; Juhana Frösen; Sara Keränen; Bart A. A. Franx; Ana-Rita Bras; Estelle R. Louet; Ádám Dénes; Mario Merlini; Denis Vivien; Marina Rubio. CNS-associated macrophages contribute to intracerebral aneurysm pathophysiology. Acta Neuropathologica Communications 12, article 43. DOI 10.1186/s40478-024-01756-5. Online 2024-03-18; issue 2024. Article-number publication; no separate issue number/page range verified. Primary bibliographic record.

  3. Clara Correa-Paz; María Pérez-Mato; Mathys Bellemain-Sagnard; Marco González-Domínguez; Pauline Marie; Lara Pérez-Gayol; Esteban López-Arias; Lucia Del Pozo-Filíu; Sonia López-Amoedo; Ana Bugallo-Casal; María Luz Alonso-Alonso; María Candamo-Lourido; María Santamaría-Cadavid; Susana Arias-Rivas; Manuel Rodríguez-Yañez; Ramón Iglesias-Rey; José Castillo; Denis Vivien; Marina Rubio; Francisco Campos. Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke. Journal of Cerebral Blood Flow & Metabolism 44(8), 1306–1318. DOI 10.1177/0271678X241237427. Online 2024-03-04; issue 2024-08. Exact issue day unconfirmed. Primary bibliographic record.

Funding, application, living cost and career evidence

Sources

The listing may come from a university or recruitment platform. Check the notice and official sources in the report for current application requirements. View the recruitment source

Explore opportunities with related research or the same country, prioritising similar funding where relevant. Recheck each notice before applying.

University of Montpellier · France

Paleobotany PhD: Comparing Paleozoic Wood Anatomy and Exploring Its Water-Transport Capacity

CNRS fixed-term PhD employment for 36 months, full time, scheduled to start 1 February 2027. The CNRS vacancy lists at least EUR 2,300 gross per month. This stated minimum matches the French doctoral-contract statutory minimum for 2026; the actual rate above this floor is not specified. The offer also lists 44 annual leave/RTT days, reimbursement of 75% of transport costs and a sustainable-mobility allowance up to EUR 300. The position is marked as not funded through an EU Research Framework Programme. The University lists a EUR 398 annual doctoral registration fee for 2026–27; the CVEC is EUR 105 if applicable. The offer does not state the registration category, payer or whether these charges are covered.

2026-11-27 (confirm the exact time with the source)

Degree-awarding institution not confirmed · France

PhD in generative AI for biological imaging | Tissue images and spatial molecular data

CNRS fixed-term full-time doctoral employment for 36 months, €2,300 gross per month. The notice lists 44 annual leave/RTT days, 75% transport reimbursement and a sustainable-mobility allowance up to €300; conditions and net pay remain to be confirmed. Project-specific funding source is not stated.

2026-11-27 (confirm the exact time with the source)